Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kim Frisch

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Chemical Communications (Cambridge, England)|January 23, 2008
Organocatalytic asymmetric vinylogous addition to quinones - formation of optically active alpha-aryl ketonesJosé Alemán, Christian Borch Jacobsen, Kim Frisch, et al.
Journal of Hepatology|January 24, 2013
Regional metabolic liver function measured in patients with cirrhosis by 2-[¹⁸F]fluoro-2-deoxy-D-galactose PET/CTMichael Sørensen, Kasper S Mikkelsen, Kim Frisch, et al.
Nuclear Medicine and Biology|July 23, 2019
Human biodistribution, dosimetry, radiosynthesis and quality control of the bile acid PET tracer [N-methyl-<sup>11</sup>C]cholylsarcosineKim Frisch, Kristoffer Kjærgaard, Jacob Horsager, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 31, 2011
Hepatic galactose metabolism quantified in humans using 2-18F-fluoro-2-deoxy-D-galactose PET/CTMichael Sørensen, Kasper Sandager Mikkelsen, Kim Frisch, et al.
Journal of Hepatology|March 3, 2017
Hepatobiliary transport kinetics of the conjugated bile acid tracer <sup>11</sup>C-CSar quantified in healthy humans and patients by positron emission tomographyNikolaj Worm Ørntoft, Ole Lajord Munk, Kim Frisch, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 5, 2014
The lumped constant for the galactose analog 2-18F-fluoro-2-deoxy-D-galactose is increased in patients with parenchymal liver diseaseKasper S Mikkelsen, Michael Sørensen, Kim Frisch, et al.
Nuclear Medicine and Biology|September 12, 2022
N-(4-[<sup>18</sup>F]fluorobenzyl)cholylglycine, a potential tracer for positron emission tomography of enterohepatic circulation and drug-induced inhibition of ileal bile acid transport. A proof-of-concept PET/CT study in pigsKim Frisch, Frank Viborg Mortensen, Ole Lajord Munk, et al.
Analytical Chemistry|July 19, 2024
Desorption Electrospray Ionization Mass Spectrometry Imaging of Powder-Treated Fingermarks on Forensic Gelatin Lifters and its Application for Separating Overlapping FingermarksKim Frisch, Kirstine L Nielsen, Jo Rgen B Hasselstro M, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 12, 2020
The role of dopaminergic and serotonergic transmission in the processing of primary and monetary rewardCasper Schmidt, Nikolina Skandali, Carsten Gleesborg, et al.
Nuclear Medicine and Biology|May 22, 2018
N-(4-[<sup>18</sup>F]fluorobenzyl)cholylglycine, a novel tracer for PET of enterohepatic circulation of bile acids: Radiosynthesis and proof-of-concept studies in ratsKim Frisch, Damion H R Stimson, Taracad Venkatachalam, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Chemical Communications (Cambridge, England)|January 23, 2008
Organocatalytic asymmetric vinylogous addition to quinones - formation of optically active alpha-aryl ketonesJosé Alemán, Christian Borch Jacobsen, Kim Frisch, et al.
Journal of Hepatology|January 24, 2013
Regional metabolic liver function measured in patients with cirrhosis by 2-[¹⁸F]fluoro-2-deoxy-D-galactose PET/CTMichael Sørensen, Kasper S Mikkelsen, Kim Frisch, et al.
Nuclear Medicine and Biology|July 23, 2019
Human biodistribution, dosimetry, radiosynthesis and quality control of the bile acid PET tracer [N-methyl-<sup>11</sup>C]cholylsarcosineKim Frisch, Kristoffer Kjærgaard, Jacob Horsager, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 31, 2011
Hepatic galactose metabolism quantified in humans using 2-18F-fluoro-2-deoxy-D-galactose PET/CTMichael Sørensen, Kasper Sandager Mikkelsen, Kim Frisch, et al.
Journal of Hepatology|March 3, 2017
Hepatobiliary transport kinetics of the conjugated bile acid tracer <sup>11</sup>C-CSar quantified in healthy humans and patients by positron emission tomographyNikolaj Worm Ørntoft, Ole Lajord Munk, Kim Frisch, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 5, 2014
The lumped constant for the galactose analog 2-18F-fluoro-2-deoxy-D-galactose is increased in patients with parenchymal liver diseaseKasper S Mikkelsen, Michael Sørensen, Kim Frisch, et al.
Nuclear Medicine and Biology|September 12, 2022
N-(4-[<sup>18</sup>F]fluorobenzyl)cholylglycine, a potential tracer for positron emission tomography of enterohepatic circulation and drug-induced inhibition of ileal bile acid transport. A proof-of-concept PET/CT study in pigsKim Frisch, Frank Viborg Mortensen, Ole Lajord Munk, et al.
Analytical Chemistry|July 19, 2024
Desorption Electrospray Ionization Mass Spectrometry Imaging of Powder-Treated Fingermarks on Forensic Gelatin Lifters and its Application for Separating Overlapping FingermarksKim Frisch, Kirstine L Nielsen, Jo Rgen B Hasselstro M, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 12, 2020
The role of dopaminergic and serotonergic transmission in the processing of primary and monetary rewardCasper Schmidt, Nikolina Skandali, Carsten Gleesborg, et al.
Nuclear Medicine and Biology|May 22, 2018
N-(4-[<sup>18</sup>F]fluorobenzyl)cholylglycine, a novel tracer for PET of enterohepatic circulation of bile acids: Radiosynthesis and proof-of-concept studies in ratsKim Frisch, Damion H R Stimson, Taracad Venkatachalam, et al.
Pageof 3